Details for New Drug Application (NDA): 203479
✉ Email this page to a colleague
NDA 203479 describes VERSACLOZ, which is a drug marketed by Tasman Pharma and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the VERSACLOZ profile page.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clozapine profile page.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Summary for 203479
| Tradename: | VERSACLOZ |
| Applicant: | Tasman Pharma |
| Ingredient: | clozapine |
| Patents: | 1 |
Suppliers and Packaging for NDA: 203479
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479 | NDA | TruPharma LLC | 52817-601 | 52817-601-38 | 1 BOTTLE in 1 BOX (52817-601-38) / 100 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 50MG/ML | ||||
| Approval Date: | Feb 6, 2013 | TE: | RLD: | Yes | |||||
| Patent: | 8,057,811 | Patent Expiration: | May 1, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
